4-Acetamido-N-(5-carbamoyl-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)phenyl)-benzamide

ID: ALA3612128

Chembl Id: CHEMBL3612128

PubChem CID: 122187963

Max Phase: Preclinical

Molecular Formula: C28H23N5O5

Molecular Weight: 509.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1ccc(C(=O)Nc2cc(C(N)=O)ccc2NC(=O)c2ccc(-n3ccccc3=O)cc2)cc1

Standard InChI:  InChI=1S/C28H23N5O5/c1-17(34)30-21-10-5-18(6-11-21)28(38)32-24-16-20(26(29)36)9-14-23(24)31-27(37)19-7-12-22(13-8-19)33-15-3-2-4-25(33)35/h2-16H,1H3,(H2,29,36)(H,30,34)(H,31,37)(H,32,38)

Standard InChI Key:  XSOXUBOSAFNFGZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3612128

    ---

Associated Targets(Human)

F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 509.52Molecular Weight (Monoisotopic): 509.1699AlogP: 3.40#Rotatable Bonds: 7
Polar Surface Area: 152.39Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.50CX Basic pKa: CX LogP: 2.17CX LogD: 2.17
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.30Np Likeness Score: -1.34

References

1. Yang J, Su G, Ren Y, Chen Y..  (2015)  Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.,  101  [PMID:26114810] [10.1016/j.ejmech.2015.06.012]

Source